Houston AIDS Research Team CRS*

Houston, Texas 77030

1 studies enrolling now · 28 studies all time

What they study most

Anus Neoplasms, Cardiovascular Diseases, Cytomegalovirus Infections, Drug Use, HIV, HIV Infection, HIV Infections, HIV Prevention, HIV-1-infection, Hepatitis B, Hepatitis C, LTBI

Studies at this site

• Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1 — Recruiting now
• The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE — Running, not enrolling
• INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit — Completed
• Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®) — Completed
• Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men — Completed
• Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103) — Running, not enrolling
• Pre-Exposure Prophylaxis for Transgender Women in the US and South America — Completed
• Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults — Completed
• B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B — Completed
• Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals — Stopped early
• Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND) — Completed
• Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART) — Completed
• Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection — Completed
• Combination Pain Therapy in HIV Neuropathy — Stopped early
• Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy — Stopped early
• Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women — Completed
• Optimizing Treatment for Treatment-Experienced, HIV-Infected People — Completed
• Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB) — Completed
• Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women — Completed
• Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications — Completed
• Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF) — Completed
• Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults — Completed
• Comparative Study of Three NNRTI-Sparing HAART Regimens — Completed
• Collection of Blood Samples From HIV Infected People — Completed
• Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants — Completed
• A Study of Anal Cancer Development in HIV Infected People — Completed
• A Study of the Long-Term Outcomes of HIV-Positive Patients — Completed
• Long-Term Data Collection From Participants in Adult AIDS Clinical Trials — Completed